Abstract
The clinical significance of the transluminal attenuation gradient (TAG) has not been established. We evaluated the incremental diagnostic value of TAG by 320-row area detector computed tomography (320-ADCT). Subjects were 65 patients who underwent one-rotation scanning by 320-ADCT and invasive coronary angiography (ICA) within 3 months. TAG values were obtained for the major epicardial vessels 2 mm or more each in RCA, LAD and LCX using automatic analysis software. Moreover, TAG values that excluded calcified lesions in calculation of the regression line were also evaluated (excluded-TAG). In LAD, 21 intermediate lesions underwent functional flow reserve (FFR), and the incremental diagnostic value for functional stenosis was evaluated. The TAG values in the normal vessels were − 8.3 ± 5.0 (HU/cm) for the RCA (n = 32), − 23.3 ± 4.3 for the LAD (n = 9) and − 20.6 ± 10.0 for the LCX (n = 32). The RCA value was significantly higher (p < 0.001). The TAG values with stenosis degrees of ≤ 25%, 26–75%, ≥ 76% on ICA were − 8.3 ± 5.0 (n = 32) vs − 10.3 ± 7.2 (n = 25) vs − 10.0 ± 5.4 (n = 4) in the RCA, − 23.3 ± 4.3 (n = 9) vs − 21.0 ± 11.5 (n = 35) vs − 23.5 ± 15.3 (n = 10) in the LAD and − 21.1 ± 15.1 (n = 32) vs − 21.1 ± 15.1 (n = 16) vs − 17.7 ± 15.7 (n = 6) in the LCX, with no significant difference among the three groups. The excluded-TAG values also showed no significant difference. The area under the curve in the diagnosis of FFR < 0.8 in 21 LAD cases was 0.542 for CT only, 0.694 for CT + TAG, and 0.694 for CT + excluded-TAG. In single time-phase scanning by 320-ADCT, TAG does not offer an incremental diagnostic value.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
The usefulness of measuring the transluminal attenuation gradient (TAG) in conventional coronary CT angiography (CCTA) was previously reported [1], and diagnosis of significant coronary artery disease has since improved in some studies [2, 3]. However, negative results were obtained in other studies [4], and no consistent viewpoint has been reached with regard to its usefulness. In TAG, the reduction of contrast opacification by cross-sectional images along the coronary artery is measured, and it is defined as a linear regression of luminal opacification with distance from the vessel ostium. However, conventional CCTA images are constructed over several heartbeats, and the influence of this on TAG measurement has been of concern.
With 320-row area detector computed tomography (320-ADCT), a maximum of 16 cm coverage in the body axis direction became possible, allowing imaging of the entire heart by conventional scanning with a single rotation. Subsequently, TAG measurement at a single point became possible, and the variation in patient parameters was small in a preliminary study [1]. However, there are only limited reports on its usefulness in actual clinical practice [5, 6].
Automatic analysis software for TAG has recently been developed. Its accuracy and reproducibility are high, and a reduction of the analysis time by 68% compared to conventional manual measurement has been reported [7].
In this study, using automatic analysis software, the diagnostic performance of TAG using 320-ADCT for degree of stenosis and functional stenosis evaluation with fractional flow reserve (FFR) was compared.
Methods
Study population
This was a retrospective single-center study. The institutional human research committees of our institution approved the corresponding study components. Anonymous use of the test data for the study was orally explained to all subjects, and written consent was obtained. The subjects were 65 consecutive patients suspected of having coronary artery disease during a period from 1 October 2014 through 30 April 2016, and who underwent one-rotation scanning by 320-ADCT and invasive coronary angiography (ICA) within 3 months. Patients who had previously undergone revascularization (PCI and/or CABG) and patients with poor image quality were excluded.
CCTA protocol
Patients with a pre-scan heart rate ≥ 60 beats per minute were given 20–40 mg of metoprolol orally and, if the heart rate remained ≥ 61 beats per minute after 1 h, they were given an intravenous injection of landiolol (0.125 mg/kg). Patients in whom beta-blockers were contraindicated (due to severe aortic stenosis, systolic blood pressure < 90 mmHg, bronchial asthma, symptomatic heart failure, or advanced atrioventricular block) did not receive these treatments. The following devices were used: Aquilion ONE ViSION Edition™ (320-ADCT, Toshiba Medical Systems Corporation, Otawara, Japan), Dual Shot GX 7 (contrast injector, Nemoto Kyorindo Co., Ltd., Tokyo, Japan), Model 7800 ECG monitor (Chronos Medical Devices Inc., Tokyo, Japan), and Ziostation image analyzer (Zio M900, Ziosoft Inc., Tokyo, Japan). Scanning was performed at a tube voltage of 100 kV except in patients whose body mass index exceeded 30 kg/m2, who were scanned at 120 kV. The mean tube current was calculated with automatic exposure control for a standard deviation (SD) of 20. With a slice width of 0.5 mm and reconstruction interval of 0.25 mm, the minimum number of rows necessary to include all coronary arteries was selected from 200 rows (100 mm), 240 rows (120 mm), 256 rows (128 mm), 280 rows (140 mm), and 320 rows (160 mm) in reference to unenhanced CT performed when determining the calcium score. Prospective CTA mode was used for all patients, with a range of X-ray exposure of 75% of the RR interval. The contrast agent iohexol (Omnipaque 350 mg I/ml; Daiichi-Sankyo Company, Tokyo, Japan) was injected for 12 s at 18 mg I/kg/s, followed by injection of 30 mL of saline at the same rate as contrast agent injection. Intermittent prep scanning with bolus tracking at the four-chamber-view level was performed once every 0.5 s beginning 10 s after the start of contrast agent injection. Scanning was started when the contrast agent reached 300 HU at the ascending aorta. Adaptive iterative dose reduction using three-dimensional processing (AIDR3D) was used for all patients, with intensity at the standard setting.
CCTA interpretation
For plaque detection, both cross-sectional and longitudinal curved multiplanar reformation images were analyzed. Coronary artery segments with a diameter ≥ 2 mm were evaluated for the degree of stenosis. The percent ratio of the stenotic lumen to the normal vessel diameter proximal or distal to the stenosis was obtained, and the percent degree of stenosis was determined. From still images taken from multiple projections, measurements were made in the angle showing the narrowest degree of stenosis. The degree of stenosis was evaluated by consensus of two experienced cardiologists who were unaware of the clinical data. Lesions with > 50% stenosis were defined as significant. If lesion stenosis were not assessable due to calcification, lesions were defined as significant.
ICA and FFR techniques
ICA and FFR were performed according to standard clinical practice. Percent stenosis was calculated for the most significant lesion in each vessel in the angle showing the narrowest degree of stenosis. FFR was performed at the discretion of the operator. Pressure measurements were performed using a 0.014-in. pressure guide wire (Verrata Pressure Guide Wire, Volcano Corp., San Diego, CA or PressureWire Certus, St. Jude Medical Systems, Uppsala, Sweden). The pressure wire was calibrated and equalized with aortic pressure. FFR was calculated at steady-state hyperemia after intracoronary isosorbide dinitrate (0.5–1 mg) and intracoronary papaverine hydrochloride (left coronary 12 mg, right coronary 8 mg) or intravenous ATP (140 μg/kg/min) injection.
TAG measurements
TAG values were obtained for the major epicardial vessels having 2 mm or more each in RCA, LAD and LCX using automatic analysis software [7]. Where a calcified lesion is present, when the CT value of the lumen is plotted for measurement of TAG, the CT value may be markedly different. Because of this, the analysis results of the TAG value may influence the regression line. Plotted values beyond the CT value of the concentration of the contrast medium among the values plotted by automatic analysis software were removed manually and the regression line was calculated. This was defined as excluded-TAG.
Chronic total occlusion lesions, LCX-dominant RCA, LAD and LCX which showed 50% or more stenosis in LMT were excluded from the analyses.
Statistical analysis
Statistical analyses were performed using Statview J-5.0 for Windows (HULINKS Inc., Tokyo, Japan) and MedCalc Version 12.2.1. (Mariakerke, Belgium). Numerical data were expressed as the mean ± standard deviation. One-factor ANOVA was employed for comparisons between groups to determine the statistical significance of differences. Groups were compared independently using Scheffé analysis. The incremental diagnostic prediction ability of TAG for functionally significant stenosis was calculated using receiver operating characteristic (ROC) analysis and the area under the curve (AUC). Values at p < 0.05 were considered statistically in all instances.
Results
Patient characteristics
Patient characteristics are shown in Table 1.
Comparison of normal coronary TAG for 3 major coronary arteries
Vessels having lesions with ≤ 25% stenosis were defined as normal coronary vessels. The TAG values in the normal vessels were − 8.3 ± 5.0 (HU/cm) for the RCA (n = 32), − 23.3 ± 4.3 for the LAD (N = 9) and − 20.6 ± 10.0 for the LCX (n = 32). The value for RCA was significantly the highest (p < 0.001) (Fig. 1).
Comparison of TAG base in stenosis degree for 3 major coronary arteries
The TAG values in three major coronary arteries with stenosis degrees of ≤ 25%, 26–75% and ≥ 76% were − 8.3 ± 5.0 (n = 32) vs − 10.3 ± 7.2 (n = 25) vs − 10.0 ± 5.4 (n = 4) in the RCA (Fig. 2a), − 23.3 ± 4.3 (n = 9) vs − 21.0 ± 11.5 (n = 35) vs − 23.5 ± 15.3 (n = 10) in LAD (Fig. 2b), and − 21.1 ± 15.1 (n = 32) vs − 21.1 ± 15.1 (n = 16) vs − 17.7 ± 15.7 (n = 6) in LCX (Fig. 2c). There were no significant differences among the three groups based on stenosis degree. In excluded-TAG, the TAG values in the three groups were − 8.1 ± 5.1 (n = 32) vs − 9.1 ± 5.4 (n = 25) vs − 9.0 ± 5.1 (n = 4) in the RCA (Fig. 3a), − 21.9 ± 4.9 (n = 9) vs − 17.2 ± 7.9 (n = 35) vs − 16.3 ± 8.2 (n = 10) in the LAD (Fig. 3b), and − 21.9 ± 8.6 (n = 32) vs − 21.6 ± 12.3 (n = 16) vs − 20.2 ± 9.7 (n = 6) in the LCX (Fig. 3c), which also showed no significant difference among the three groups.
Incremental diagnostic value of TAG in coronary artery with intermediate stenosis for functionally significant coronary artery stenosis
Incremental values of TAG for functionally significant coronary artery stenosis were evaluated in 21 LAD vessels with intermediate stenosis in which FFR was performed. Nine of the 21 vessels had a positive FFR < 0.8. The optimal cut-off values of TAG and excluded-TAG calculated from AUC by ROC analysis were − 19.5 and − 19.5, respectively. The area under the curve in the diagnosis of FFR < 0.8 in 21 LAD cases was 0.542 (95% CI 0.314–0.758) for CT only, 0.694 (0.458–0.874) for CT + TAG, and 0.694 (0.458–0.874) for CT + excluded-TAG. Neither TAG nor excluded-TAG offered an incremental diagnostic value for functionally significant stenosis lesions in comparison with conventional CT findings (p = 0.3767) (Fig. 4). Representative cases of TAG and excluded-TAG are presented in Fig. 5.
Discussion
The usefulness of TAG analyzed by single rotation imaging using 320-ADCT was investigated, with the following three major findings. Firstly, in non-LCX-dominant patients, the TAG value in the RCA without stenosis was significantly higher than those in the LAD and LCX. Secondly, in coronary CT images of actual clinical cases, no significant differences in the TAG values due to differences in the degree of stenosis were noted in any coronary artery vessels. Thirdly, when invasive FFR was used as a reference to evaluate functional stenosis, TAG measurement in the coronary artery with moderate stenosis did not significantly increase the diagnostic value of stenosis evaluation compared with conventional coronary CT.
A significantly higher blood flow in the RCA than in the LAD and LCX in non-LCX-dominant patients has been reported [8]. TAG on 320-ADCT reflects the difference in contrast medium concentration between coronary segments in the same time phase, and this may be dependent on the coronary blood flow velocity. Assuming that the diameter of the main epicardial coronary artery does not normally change, TAG is mostly related to coronary blood flow. In addition, as for RCA, at the systolic phase, the constriction from RV is smaller than that from LV. Thus, the blood flow is different from that at the left coronary artery and this may influence the TAG value. The TAG value was significantly higher in the normal RCA in this study, and this finding makes sense. However, differences among the coronary vessels were not considered in most previous reports [2,3,4,5,6]. We suggest that it is necessary to set a cut-off value for each coronary vessel to evaluate TAG.
Theoretically, TAG may reflect coronary blood flow at rest [9]. Constant resting coronary blood flow is usually maintained by adjusting vascular resistance in microcirculation until the condition reaches severe stenosis exceeding 75% [10], based on which we established three groups—a severe stenosis group in which blood flow may have decreased even at rest, a moderate stenosis group in which blood flow was not reduced but the reserve was reduced, and a mostly normal mild-normal stenosis group—and compared the TAG values among the groups, but no significant difference was noted in any coronary branch among the three groups even in the group with severe stenosis that is assumed to influence the TAG value. When CCTA is imaged in a condition of hyperemia and the TAG is measured, the result may be different. However, this cancels out the merit of the ability to measure the TAG by conventional CCTA. Single rotation imaging using 320-row coronary CT is capable of TAG analysis in a single time-phase, and the acquisition protocol was consistent in all cases because this was a single-center study. Differences in coronary blood flow within a specific time-phase may reflect the contrast medium concentration gradient, but when reduction of blood flow is not marked, the contrast medium concentration may rapidly become homogeneous in the entire coronary artery by continuous contrast medium injection. Moreover, the timing of filling the coronary artery with contrast medium is influenced by the cardiac output and blood pressure in individual patients. Therefore, even when an identical acquisition protocol is used, it is very difficult to consistently acquire images in the time phase in which blood flow is reflected as the contrast medium concentration gradient assumed to be kept for a very short time in actual clinical practice. Moreover, although coronary blood flow is influenced by the heart rate, blood pressure, and ventricular mass size [11], no significant difference was noted in the heart rate or blood pressure among the three groups. The ventricular mass size could not be investigated in this study.
In addition, high X-ray absorbents, such as calcification and stents, may influence the TAG value. Stented patients were excluded from this study. We performed analysis excluding calcified regions in cases with calcification, but the results did not change, as previously reported [4]. The acquisition timing is also a very important factor of TAG analysis on single rotation imaging using 320-ADCT, and it is not practical to always identify the acquisition timing and acquire images in consideration of TAG analysis in actual clinical practice.
We investigated whether or not TAG measurement increases the diagnostic value of moderate stenosis evaluation using conventional coronary CT and invasive FFR as a reference. It is possible that the cut-off value of TAG differed among the coronary vessels in this study. Thus, only cases in which invasive FFR was applied to the LAD were included. The addition of the TAG value tended to increase AUC compared with that on conventional CT alone, but no significant increase in the diagnostic value was noted. The major cause of this was that TAG reflects coronary blood flow at rest, as described above, and it may have no useful additional value for diagnosing moderate stenosis in which constant resting coronary blood flow may be maintained. In addition to TAG, the usefulness of perfusion CT [12, 13] and FFR-CT [14,15,16] as a functional stenosis evaluation method using coronary CT has recently been reported. Although TAG is the simplest method with which analysis can be performed within the conventional coronary CT acquisition range and short time among these, the fact that it is simple could be irrelevant as it did not offer an incremental diagnostic value in comparison with conventional CCTA. Recently, FFR-CT has markedly developed: analysis can be performed by conventional coronary imaging, and the analysis time is shorter [17, 18]. It has also been reported that when invasive FFR was used as a reference, the diagnostic accuracy of FFR-CT was significantly higher than that of TAG [19, 20]. It was recently reported that the TAG-based contrast medium concentration gradient is a secondary result due to differences in coronary diameter [21]. Further study may be necessary with regard to the clinical significance of TAG measurement.
Limitation
There were some limitations in the present study. Firstly, this was a single-center retrospective study and the patient number was small. Especially, the incremental diagnostic value for functional stenosis diagnosis was evaluated in only 21 vessels. Since no usefulness of TAG was noted using the specified acquisition protocol at a single institution, further study on the use of TAG in actual clinical practice may be necessary. Secondly, the intra- and inter-reproducibility of TAG measurement was not determined. However, automatic analysis software was used for measurement, and its reproducibility has been reported [7]. Thirdly, we consider it important to investigate the clinical significance of TAG in real-world protocols having favorable CCTA imaging as a major purpose. If a major purpose of the imaging is the evaluation of TAG, a shorter contrast bolus could be advantageous, but if this influences CCTA images, it could be counterproductive. However, we did not investigate the usefulness of TAG with different protocols.
References
Steigner ML, Mitsouras D, Whitmore AG, Otero HJ, Wang C, Buckley O, Levit NA, Hussain AZ, Cai T, Mather RT, Smedby O, DiCarli MF, Rybicki FJ (2010) Iodinated contrast opacification gradients in normal coronary arteries imaged with prospectively ECG-gated single heart beat 320-detector row computed tomography. Circ Cardiovasc Imaging 3:179–186
Choi JH, Koo BK, Yoon YE, Min JK, Song YB, Hahn JY, Choi SH, Gwon HC, Choe YH (2012) Diagnostic performance of intracoronary gradient-based methods by coronary computed tomography angiography for the evaluation of physiologically significant coronary artery stenoses: a validation study with fractional flow reserve. Eur Heart J Cardiovasc Imaging 13:1001–1007
Choi JH, Min JK, Labounty TM, Lin FY, Mendoza DD, Shin DH, Ariaratnam NS, Koduru S, Granada JF, Gerber TC, Oh JK, Gwon HC, Choe YH (2011) Intracoronary transluminal attenuation gradient in coronary CT angiography for determining coronary artery stenosis. JACC Cardiovasc Imaging 4:1149–1157
Stuijfzand WJ, Danad I, Raijmakers PG, Marcu CB, Heymans MW, van Kuijk CC, van Rossum AC, Nieman K, Min JK, Leipsic J, van Royen N, Knaapen P (2014) Additional value of transluminal attenuation gradient in CT angiography to predict hemodynamic significance of coronary artery stenosis. JACC Cardiovasc Imaging 7:374–386
Wong DT, Ko BS, Cameron JD, Nerlekar N, Leung MC, Malaiapan Y, Crossett M, Leong DP, Worthley SG, Troupis J, Meredith IT, Seneviratne SK (2013) Transluminal attenuation gradient in coronary computed tomography angiography is a novel noninvasive approach to the identification of functionally significant coronary artery stenosis: a comparison with fractional flow reserve. J Am Coll Cardiol 61:1271–1279
Wong DTL, Ko BS, Cameron JD, Leong DP, Leung MCH, Malaiapan Y, Nerlekar N, Crossett M, Troupis J, Meredith IT, Seneviratne SK (2014) Comparison of diagnostic accuracy of combined assessment using adenosine stress computed tomography perfusion + computed tomography angiography with transluminal attenuation gradient + computed tomography angiography against invasive fractional flow reserve. J Am Coll Cardiol 63:1904–1912
Chatzizisis YS, George E, Cai T, Fulwadhva UP, Kumamaru KK, Schultz K, Fujisawa Y, Rassi C, Steigner M, Mather RT, Blankstein R, Rybicki FJ, Mitsouras D (2014) Accuracy and reproducibility of automated, standardized coronary transluminal attenuation gradient measurements. Int J Cardiovasc Imaging 30:1181–1189
Sakamoto S, Takahashi S, Coskun AU, Papafaklis MI, Takahashi A, Saito S, Stone PH, Feldman CL (2013) Relation of distribution of coronary blood flow volume to coronary artery dominance. Am J Cardiol 111:1420–1424
Chow BJ, Kass M, Gagne O, Chen L, Yam Y, Dick A, Wells GA (2011) Can differences in corrected coronary opacification measured with computed tomography predict resting coronary artery flow? J Am Coll Cardiol 57:1280–1288
Gould KL, Lipscomb K, Hamilton GW (1974) Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol 33:87–94
Wieneke H, von Birgelen C, Haude M, Eggebrecht H, Mohlenkamp S, Schmermund A, Bose D, Altmann C, Bartel T, Erbel R (2005) Determinants of coronary blood flow in humans: quantification by intracoronary Doppler and ultrasound. J Appl Physiol (1985) 98:1076–1082
Bamberg F, Becker A, Schwarz F, Marcus RP, Greif M, von Ziegler F, Blankstein R, Hoffmann U, Sommer WH, Hoffmann VS, Johnson TR, Becker HC, Wintersperger BJ, Reiser MF, Nikolaou K (2011) Detection of hemodynamically significant coronary artery stenosis: incremental diagnostic value of dynamic CT-based myocardial perfusion imaging. Radiology 260:689–698
Becker A, Becker C (2013) CT imaging of myocardial perfusion: possibilities and perspectives. J Nucl Cardiol 20:289–296
Koo BK, Erglis A, Doh JH, Daniels DV, Jegere S, Kim HS, Dunning A, DeFrance T, Lansky A, Leipsic J, Min JK (2011) Diagnosis of ischemia-causing coronary stenoses by noninvasive fractional flow reserve computed from coronary computed tomographic angiograms. Results from the prospective multicenter DISCOVER-FLOW (diagnosis of ischemia-causing stenoses obtained via noninvasive fractional flow reserve) study. J Am Coll Cardiol 58:1989–1997
Min JK, Leipsic J, Pencina MJ, Berman DS, Koo BK, van Mieghem C, Erglis A, Lin FY, Dunning AM, Apruzzese P, Budoff MJ, Cole JH, Jaffer FA, Leon MB, Malpeso J, Mancini GB, Park SJ, Schwartz RS, Shaw LJ, Mauri L (2012) Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA 308:1237–1245
Norgaard BL, Leipsic J, Gaur S, Seneviratne S, Ko BS, Ito H, Jensen JM, Mauri L, De Bruyne B, Bezerra H, Osawa K, Marwan M, Naber C, Erglis A, Park SJ, Christiansen EH, Kaltoft A, Lassen JF, Botker HE, Achenbach S, Group NXTTS (2014) Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (analysis of coronary blood flow using CT angiography: next steps). J Am Coll Cardiol 63:1145–1155
Coenen A, Lubbers MM, Kurata A, Kono A, Dedic A, Chelu RG, Dijkshoorn ML, Gijsen FJ, Ouhlous M, van Geuns RJ, Nieman K (2015) Fractional flow reserve computed from noninvasive CT angiography data: diagnostic performance of an on-site clinician-operated computational fluid dynamics algorithm. Radiology 274:674–683
Ko BS, Cameron JD, Munnur RK, Wong DTL, Fujisawa Y, Sakaguchi T, Hirohata K, Hislop-Jambrich J, Fujimoto S, Takamura K, Crossett M, Leung M, Kuganesan A, Malaiapan Y, Nasis A, Troupis J, Meredith IT, Seneviratne SK (2017) Noninvasive CT-derived FFR based on structural and fluid analysis: a comparison with invasive FFR for detection of functionally significant stenosis. JACC Cardiovasc Imaging 10:663–673
Yoon YE, Choi JH, Kim JH, Park KW, Doh JH, Kim YJ, Koo BK, Min JK, Erglis A, Gwon HC, Choe YH, Choi DJ, Kim HS, Oh BH, Park YB (2012) Noninvasive diagnosis of ischemia-causing coronary stenosis using CT angiography: diagnostic value of transluminal attenuation gradient and fractional flow reserve computed from coronary CT angiography compared to invasively measured fractional flow reserve. JACC Cardiovasc Imaging 5:1088–1096
Ko BS, Wong DT, Norgaard BL, Leong DP, Cameron JD, Gaur S, Marwan M, Achenbach S, Kuribayashi S, Kimura T, Meredith IT, Seneviratne SK (2016) Diagnostic performance of transluminal attenuation gradient and noninvasive fractional flow reserve derived from 320-detector row CT angiography to diagnose hemodynamically significant coronary stenosis: an NXT substudy. Radiology 279:75–83
Park EA, Lee W, Park SJ, Kim YK, Hwang HY (2016) Influence of coronary artery diameter on intracoronary transluminal attenuation gradient during CT angiography. JACC Cardiovasc Imaging 9:1074–1083
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Daida has received speakers’ Bureau/Honoraria from Astellas Pharma Inc., AstraZeneca K. K., MSD. K. K., Kyowa Hakko Kirin Company, Ltd., Kowa Pharmaceutical Company, Ltd., Daiichi-Sankyo Company, Ltd., Takeda Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corp., Bayer Yakuhin, Ltd., as well as research funds from Kyowa Hakko Kirin Company Ltd., Philips Electronics Japan, Ltd. Astellas Pharma Inc., ABBOTT JAPAN CO., Ltd., Sanofi K. K., Eisai Co., Ltd., Shionogi & Co., Ltd., Daiichi-Sankyo Company, Ltd., Dainippon Sumitomo Pharma Co., Ltd., Takeda Pharmaceutical Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., Bayer Yakuhin, Ltd., Pfizer Co., Ltd., Philips Electronics Japan, Ltd., FUJIFILM Corporation, Bristol-Myers Squibb Company, Boston Scientific Japan K. K., SANWA KAGAKU KENKYUSHO Co., Ltd., MSD. K. K. and Toshiba Medical Systems that are unrelated to this project. All other authors have no potential conflict of interest.
Rights and permissions
About this article
Cite this article
Kato, E., Fujimoto, S., Takamura, K. et al. Clinical significance of transluminal attenuation gradient in 320-row area detector coronary CT angiography. Heart Vessels 33, 462–469 (2018). https://doi.org/10.1007/s00380-017-1081-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-017-1081-5